Antraciklin: Razlika med redakcijama

Antraciklini so med najučinkovitejšimi protirakavimi učinkovinami. Delujejo na najširši spekter rakavih obolenj med vsemi protitumornimi zdravili.<ref name=Weiss>{{cite journal |author=Weiss RB |title=The anthracyclines: will we ever find a better doxorubicin? |journal=Semin. Oncol. |volume=19 |issue=6 |pages=670–86 |year=december 1992 |month=december |pmid=1462166 |doi= |url=}}</ref><ref name=Minotti>{{cite journal |authorauthor1=Minotti G,|author2= Menna P,|author3= Salvatorelli E,|author4= Cairo G,|author5= Gianni L |title=Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity |journal=Pharmacol. Rev. |volume=56 |issue=2 |pages=185–229 |year=junij 2004 |month=junij |pmid=15169927 |doi=10.1124/pr.56.2.6 |url=}}</ref><ref name=Peng>{{cite journal |authorauthor1=Peng X,|author2= Chen B,|author3= Lim CC,|author4= Sawyer DB |title=The cardiotoxicology of anthracycline chemotherapeutics: translating molecular mechanism into preventative medicine |journal=Mol. Interv. |volume=5 |issue=3 |pages=163–71 |year=junij 2005 |month=junij |pmid=15994456 |doi=10.1124/mi.5.3.6 |url=}}</ref> Poglavitni [[neželeni učinek|neželeni učinki]] so škodljivo delovanje na [[srce]] (kar omejuje njihovo uporabo) in [[bruhanje]].